Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report

Acta Derm Venereol. 2021 Nov 10;101(11):adv00589. doi: 10.2340/00015555-3888.

Authors

Karim Souaid, Bénédicte Oulès, Pierre Sohier, Lydia Deschamps, Sélim Aractingi¹, Nicolas Dupin

Affiliation

¹ Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP Centre-Université de Paris, 89 rue d'Assas, FR-75006 Paris, France. [email protected].

No abstract available

Publication types

Case Reports

MeSH terms

COVID-19 Vaccines
COVID-19*
Chilblains*
Humans
Interferon Type I*
RNA, Messenger / genetics
SARS-CoV-2

Substances

COVID-19 Vaccines
Interferon Type I
RNA, Messenger